Form 4 for EW Edwards Lifesciences
Accepted 2023-12-13 00:00:00 ET · period of report 2023-12-13 · accession 0001225208-23-011074 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-12-13 | 2023-12-13 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | M - OptEx | $36.75 | +8,000 | 47.5K | +20% | +$294.0K |
| D | 2023-12-13 | 2023-12-13 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | S - Sale+OE | $71.86 | -8,000 | 39.5K | -17% | -$574.9K |
| D | 2023-12-13 | 2023-12-13 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | M - OptEx | $0.00 | -8,000 | 48.0K | -14% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-13 | M | A | 8,000 | $36.75 | 47,502.69 | D | — | — | |
| 2 | Common | Common Stock | 2023-12-13 | S | D | 8,000 | $71.86 | 39,502.69 | D | — | — | |
| 3 | Derivative | Employee Stock Option (Right to Acquire) | 2023-12-13 | M | D | 8,000 | $0.00 | 48,000 | D | $36.75 · 2017-06-11 to 2024-05-10 | 8,000 Common Stock |